Search

GlaxoSmithKline PLC

Închisă

SectorSănătate

1,389.5 -0.22

Rezumat

Modificarea prețului

24h

Curent

Minim

1378.5

Maxim

1397

Indicatori cheie

By Trading Economics

Venit

559M

501M

Vânzări

105M

8.1B

P/E

Medie Sector

21.557

57.333

EPS

23.2

Randament dividend

4.79

Marjă de profit

6.172

Angajați

68,629

EBITDA

-52M

1.1B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+13.6% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.79%

2.63%

Următoarele câștiguri

30 apr. 2025

Data viitoare de dividende

10 iul. 2025

Următoarea dată ex-dividende

15 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-5.9B

54B

Deschiderea anterioară

1389.72

Închiderea anterioară

1389.5

GlaxoSmithKline PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 apr. 2025, 09:39 UTC

Principalele dinamici ale pieței

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

5 feb. 2025, 11:32 UTC

Câștiguri

GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook -- 2nd Update

5 feb. 2025, 08:56 UTC

Câștiguri

Correction to GSK Article

5 feb. 2025, 08:24 UTC

Câștiguri

GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After Beating Market Views -- Update

5 feb. 2025, 07:43 UTC

Câștiguri

GSK Expects Further Profit Growth After Beating Market Views

23 apr. 2025, 21:48 UTC

Top știri

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 apr. 2025, 20:47 UTC

Top știri

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 apr. 2025, 20:40 UTC

Top știri

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

15 apr. 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 apr. 2025, 07:23 UTC

Market Talk

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 apr. 2025, 08:41 UTC

Market Talk

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 apr. 2025, 08:36 UTC

Market Talk

U.K. Pharma to Have Some Share-Price Volatility But Long-Term Outlook Remains Intact -- Market Talk

3 apr. 2025, 07:51 UTC

Market Talk

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

2 apr. 2025, 09:27 UTC

Acțiuni populare

Stocks to Watch Wednesday: Tesla, Newsmax, Novo Nordisk -- WSJ

26 mar. 2025, 22:29 UTC

Top știri

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26 mar. 2025, 19:19 UTC

Top știri

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26 mar. 2025, 17:39 UTC

Top știri

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

19 mar. 2025, 14:50 UTC

Top știri

HIV Drug Makers Get Spooked by Trump Cuts, but Impact Looks Manageable -- Heard on the Street -- WSJ

17 mar. 2025, 09:00 UTC

Top știri

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

24 feb. 2025, 07:05 UTC

Achiziții, Fuziuni, Preluări

GSK Completes Acquisition of IDRx

14 feb. 2025, 11:38 UTC

Top știri
Câștiguri

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 feb. 2025, 11:30 UTC

Top știri
Câștiguri

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

5 feb. 2025, 15:33 UTC

Market Talk
Câștiguri

GSK's Pipeline Has to Prove It Can Counter Concerns Over Vaccine Business -- Market Talk

5 feb. 2025, 08:38 UTC

Market Talk
Câștiguri

GSK Needs to Show It Can Navigate Vaccines Challenge -- Market Talk

5 feb. 2025, 07:05 UTC

Câștiguri

GSK PLC Had Seen 2031 Sales Outlook at More Than GBP38B

5 feb. 2025, 07:04 UTC

Câștiguri

GSK PLC Sees 2031 Sales Outlook at More Than GBP40B

5 feb. 2025, 07:03 UTC

Câștiguri

GSK PLC Sees 2025 Adjusted EPS Growth of 6%-8%

5 feb. 2025, 07:03 UTC

Câștiguri

GSK PLC Raises Mid-Term View

5 feb. 2025, 07:03 UTC

Câștiguri

GSK PLC Sees 2025 Adjusted Operating Growth of 6% - 8%

5 feb. 2025, 07:02 UTC

Câștiguri

GSK PLC Sees 2025 Turnover Growth of 3% to 5%

GlaxoSmithKline PLC Așteptări

Obiectiv de preț

By TipRanks

13.6% sus

Prognoză pe 12 luni

Medie 1,583.64 GBX  13.6%

Maxim 2,290 GBX

Minim 1,350 GBX

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruGlaxoSmithKline PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

11 ratings

1

Cumpărare

8

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.